SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-13-055361
Filing Date
2013-10-16
Accepted
2013-10-16 09:18:44
Documents
3
Period of Report
2013-10-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v357454_8k.htm 8-K 15143
2 EXHIBIT 99.1 v357454_ex99-1.htm EX-99.1 8185
3 GRAPHIC image_001.jpg GRAPHIC 3104
  Complete submission text file 0001144204-13-055361.txt   28941
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

IRS No.: 223542636 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15697 | Film No.: 131153259
SIC: 2834 Pharmaceutical Preparations